Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

AAM. 2021; 10(4): 397-413


Potential of Saraswata Ghrita against Alzheimer’s disease- A review

Robin Badal, Shreshtha Kaushik, Pramod Yadav, Pradeep K. Prajapati.




Abstract

Dementia is a chronic or progressive syndromic depiction of diverse pathologies of brain. Alzheimer’s disease (AD) is the most common form of Senile dementia. Several multi-target therapeutic strategies, being utilized for AD treatment are limited to manage the symptoms only and can lead to some severe side effects. Ayurveda has dedicated a whole branch for management of ageing disorders termed as Rasayana(rejuvenate)-Vajikarana (revitalize). Saraswata Ghrita (SG), a multicomponent traditional formulation is well-known for its use as a memory enhancer. It also confers good speech, intelligence, memory and digestive power. Classical texts of Ayurveda were reviewed in a comprehensive manner and online databases as well as search engines for published researches. On Screening, it was observed that SG is quoted in around fourteen classical treatises. It has been alluded predominantly for its effect on cognitive functions of brain taking Medhya or Smrutivardhaka (memory enhancer) into account. Thus, it can be concluded that whole formulation i.e. Saraswat ghrita can be proven effective in Alzheimer’s disease.

Key words: Alzheimers disease, Ayurveda memory enhancer, Neuroprotective, Saraswata Ghrita






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.